Journal List > J Korean Ophthalmol Soc > v.55(4) > 1009939

Im, Shin, Kim, and Park: Analysis of Factors Associated with Retinal Vascular Caliber in Normal Korean Subjects

Abstract

Purpose

To measure the diameter of the retinal arterial and venous caliber of normal Korean subjects and evaluate the factors affecting these diameters.

Methods

Fundus photography was performed on 152 normal Korean subjects. Central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE) were measured with a computer-based program (IVAN), and were used to investigate the relationship between the diameter and factors including age, gender, hypertension, diabetes, and smoking.

Results

Among the study subjects, the CRVE was 209.33 ± 12.40 μm and the CRAE was 149.70 ± 9.01 μm. The CRVE and CRAE decreased with increasing age in all study subjects (both p < 0.001). There were significant gender differences in the CRVE and CRAE (p = 0.002, p = 0.042, respectively). After adjusting for age and gender, the hypertension group showed smaller CRVE and CRAE than the non-hypertension group (p = 0.038, p = 0.032, respectively). Smoking and diabetes were not significant factors affecting the CRAE and CRVE (both p > 0.05).

Conclusions

In our study group, retinal vascular caliber of normal Korean subjects decreased with aging. Retinal vascular caliber was affected by gender and hypertension, but not by smoking and diabetes.

References

1. Wong TY, Kamineni A, Klein R, et al. Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med. 2006; 166:2388–94.
2. Ikram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular dis-orders? The rotterdam study. Invest Ophthalmol Vis Sci. 2004; 45:2129–34.
crossref
3. Wong TY, Islam FM, Klein R, et al. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multiethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci. 2006; 47:2341–50.
crossref
4. McGeechan K, Liew G, Macaskill P, et al. Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med. 2009; 151:404–13.
crossref
5. Ikram MK, de Jong FJ, Bos MJ, et al. Retinal vessel diameters and risk of stroke: the rotterdam study. Neurology. 2006; 66:1339–43.
crossref
6. McGeechan K, Liew G, Macaskill P, et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol. 2009; 170:1323–32.
crossref
7. Jeganathan VS, Sabanayagam C, Tai ES, et al. Retinal vascular caliber and diabetes in a multiethnic asian population. Microcirculation. 2009; 16:534–43.
crossref
8. Islam FM, Nguyen TT, Wang JJ, et al. Quantitative retinal vascular calibre changes in diabetes and retinopathy: the Singapore Malay eye study. Eye (Lond). 2009; 23:1719–24.
crossref
9. Ikram MK, Janssen JA, Roos AM, et al. Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the rotterdam study. Diabetes. 2006; 55:506–10.
10. Wong TY, Duncan BB, Golden SH, et al. Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Invest Ophthalmol Vis Sci. 2004; 45:2949–54.
crossref
11. Liew G, Sharrett AR, Wang JJ, et al. Relative importance of systemic determinants of retinal arteriolar and venular caliber: The atherosclerosis risk in communities study. Arch Ophthalmol. 2008; 126:1404–10.
12. Klein R, Klein BE, Knudtson MD, et al. Are inflammatory factors related to retinal vessel caliber? The beaver dam eye study. Arch Ophthalmol. 2006; 124:87–94.
13. Nguyen TT, Wang JJ, Sharrett AR, et al. Relationship of retinal vascular caliber with diabetes and retinopathy: the multiethnic study of atherosclerosis (MESA). Diabetes Care. 2008; 31:544–9.
14. Myers CE, Klein R, Knudtson MD, et al. Determinants of retinal venular diameter: the beaver dam eye study. Ophthalmology. 2012; 119:2563–71.
crossref
15. Zheng Y, Cheung N, Aung T, et al. Relationship of retinal vascular caliber with retinal nerve fiber layer thickness: the Singapore Malay eye study. Invest Ophthalmol Vis Sci. 2009; 50:4091–6.
crossref
16. Schoenborn CA, Adams PE. Health behaviors of adults: United states, 2005-2007. Vital Health Stat 10. 2010; 245:1–132.
17. Scott WK, Schmidt S, Hauser MA, et al. Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. Ophthalmology. 2007; 114:1151–6.
crossref
18. Grading diabetic retinopathy from stereoscopic color fundus pho-tographs--an extension of the modified airlie house classification. ETDRS report number 10. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991; 98:786–806.
19. Leung H, Wang JJ, Rochtchina E, et al. Computer-assisted retinal vessel measurement in an older population: correlation between right and left eyes. Clin Experiment Ophthalmol. 2003; 31:326–30.
crossref
20. Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hyper-tension/sclerosis in the atherosclerosis risk in communities study. Ophthalmology. 1999; 106:2269–80.
21. Knudtson MD, Lee KE, Hubbard LD, et al. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res. 2003; 27:143–9.
crossref
22. Bewick V, Cheek L, Ball J. Statistics review 10: further non-parametric methods. Critical Care. 2004; 8:196–9.
23. McBane RD 2nd, Hardison RM, Sobel BE. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator anti-gen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial). Am J Cardiol. 2010; 105:17–24.
crossref
24. Wong TY, Klein R, Klein BE, et al. Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci. 2003; 44:4644–50.
crossref
25. Leung H, Wang JJ, Rochtchina E, et al. Relationships between age, blood pressure, and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci. 2003; 44:2900–4.
crossref
26. Wong TY, Knudtson MD, Klein BE, et al. Estrogen replacement therapy and retinal vascular caliber. Ophthalmology. 2005; 112:553–8.
crossref
27. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The atherosclerosis risk in communities study. JAMA. 2002; 287:1153–9.
crossref
28. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people: The cardiovascular health study. Br J Ophthalmol. 2002; 86:1007–13.
crossref
29. Iida M, Iida H, Dohi S, et al. Mechanisms underlying cere-brovascular effects of cigarette smoking in rats in vivo. Stroke. 1998; 29:1656–65.
crossref
30. Sharrett AR, Ding J, Criqui MH, et al. Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the multiethnic study of atherosclerosis (MESA). Atherosclerosis. 2006; 186:441–7.
crossref

Figure 1.
Fundus photograph centered at the optic disc of right eye, grader analysis measures arteries and veins, the largest six arteries (red) and veins (blue) are used to calculate the central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE) by the “Big 6” method. Yellow line is the vessel indicator of the IVAN. DD = disc diameter.
jkos-55-548f1.tif
Figure 2.
(A) Central retinal vein caliber (CRVE) for all participants at a given age, (B) Central artery caliber (CRAE) for all participants at a given age. Scattering plot shows negative correlation with age and retinal vascular caliber.
jkos-55-548f2.tif
Table 1.
Demographic characteristics of study participants stratified by age group
Age group (years) 20-29 30-39 40-49 50-59 60-69 70-79 All p-value
Number of patients 54 26 18 26 18 10 152  
Sex (male:female) 35:19 14:12 8:10 13:13 8:10 5:5 83:69 0.537*
HTN (n (%)) 0 0 2 (11.1) 8 (30.8) 11 (61.1) 5 (50.0) 26 (17.1) <0.001
DM (n (%)) 0 0 2 (11.1) 2 (7.7) 4 (22.2) 4 (40.0) 12 (7.9) <0.001
Smoker (n (%)) 4 (7.4) 4 (15.4) 2 (11.1) 4 (15.4) 5 (27.8) 1 (10.0) 20 (13.2) 0.363
Axial length (mm) 24.01 ± 0.99 24.24 ± 0.60 23.94 ± 0.52 23.89 ± 0.57 23.78 ± 0.32 23.91 ± 0.47 23.97 ± 0.67 0.425

Values are presented as mean ± SD.

HTN = hypertension; DM = diabetes mellitus.

* Comparison among age groups by Chi-square test

Fisher's exact test

ANOVA test.

Table 2.
Comparison of retinal vascular calibers with age group
  Age group (years) CRVE (μm) CRAE (μm) AVR
All 20-29 212.36 ± 12.34 152.18 ± 9.11 0.72 ± 0.05
  30-39 211.14 ± 13.95 151.04 ± 9.93 0.72 ± 0.04
  40-49 210.34 ± 10.32 149.50 ± 7.36 0.71 ± 0.03
  50-59 207.53 ± 12.01 148.61 ± 7.56 0.72 ± 0.04
  60-69 204.60 ± 8.86 146.28 ± 9.01 0.72 ± 0.04
  70-79 199.59 ± 8.86 142.18 ± 7.28 0.71 ± 0.02
  Total 209.33 ± 12.19 149.70 ± 9.01 0.72 ± 0.04
  p-value* <0.001 <0.001 0.657
Male 20-29 214.25 ± 10.12 152.98 ± 8.41 0.72 ± 0.04
  30-39 213.65 ± 11.95 151.61 ± 10.28 0.71 ± 0.05
  40-49 213.31 ± 8.06 150.92 ± 7.10 0.71 ± 0.02
  50-59 210.98 ± 9.08 150.09 ± 7.01 0.71 ± 0.03
  60-69 207.04 ± 9.75 147.66 ± 8.33 0.71 ± 0.05
  70-79 203.27 ± 6.54 144.04 ± 6.28 0.71 ± 0.01
  Total 212.19 ± 10.14 151.05 ± 8.44 0.71 ± 0.04
  p-value* 0.016 0.012 0.827
Female 20-29 208.88 ± 15.34 150.69 ± 10.35 0.72 ± 0.05
  30-39 208.21 ± 16.00 150.37 ± 9.91 0.72 ± 0.03
  40-49 207.96 ± 11.68 148.37 ± 7.75 0.71 ± 0.03
  50-59 204.09 ± 13.86 147.13 ± 8.07 0.72 ± 0.04
  60-69 202.65 ± 8.06 145.17 ± 9.81 0.72 ± 0.03
  70-79 195.91 ± 9.99 140.32 ± 8.44 0.72 ± 0.02
  Total 205.88 ± 13.55 148.07 ± 9.45 0.72 ± 0.04
  p-value* 0.048 0.023 0.26

Values are presented as mean ± SD.

CRVE = central retinal vein equivalent; CRAE = central retinal artery equivalent; AVR = arteriovenous ratio.

* Comparison among age groups by Jonckheere-Terpstra test.

Table 3.
Relationship of retinal vascular calibers with association factors
  CRVE (μm) CRAE (μm) AVR
HTN (yes/no) 203.93 ± 2.60   209.65 ±2.31 146.44 ± 1.93 1 150.82 ± 1.72 0.71 ± 0.0 05 0 .72 ± 0.04
p-value*   0.038     0.032     0.988  
DM (yes/no) 205.20 ± 3.52   208.38 ± 1.69 148.30 ± 2.61   148.96 ± 1.26 0.72 ± 0.0 04 0 .72 ± 0.05
p-value*   0.393     0.811     0.985  
p-value Smoker/non smoker 208.08 ± 3.04 0.393 2 205.50 ± 1.97 149.68 ± 2.26 0.811 147.59 ± 1.46 0.72 ± 0.0 0.98504 0 .72 ± 0.04
p-value*   0.403     0.361     0.994  

Values are presented as mean ± SD.

HTN = hypertension; DM = diabetes mellitus; CRVE = central retinal vein equivalent; CRAE = central retinal artery equivalent; AVR = arteriovenous ratio.

* Using ANCOVA with adjustment for age, sex, hypertension, diabetic mellitus, smoking.

TOOLS
Similar articles